These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 34372559)

  • 1. Chk1 and the Host Cell DNA Damage Response as a Potential Antiviral Target in BK Polyomavirus Infection.
    Hainley LE; Hughson MS; Narendran A; Smith R; Arthur J; Hayner-Buchan A; Conti DJ; Lehman JM; Friedrich TD
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BK Polyomavirus Activates the DNA Damage Response To Prolong S Phase.
    Justice JL; Needham JM; Thompson SR
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31043526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
    Gabardi S; Ramasamy S; Kim M; Klasek R; Carter D; Mackenzie MR; Chandraker A; Tan CS
    Transpl Infect Dis; 2015 Aug; 17(4):536-43. PubMed ID: 25989423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of ATM and ATR-mediated DNA damage responses during lytic BK polyomavirus infection.
    Jiang M; Zhao L; Gamez M; Imperiale MJ
    PLoS Pathog; 2012; 8(8):e1002898. PubMed ID: 22952448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes.
    Bischof N; Hirsch HH; Wehmeier C; Amico P; Dickenmann M; Hirt-Minkowski P; Steiger J; Menter T; Helmut H; Schaub S
    Nephrol Dial Transplant; 2019 Jul; 34(7):1240-1250. PubMed ID: 30476254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor.
    Lorentzen EM; Henriksen S; Kaur A; Kro GB; Hammarström C; Hirsch HH; Midtvedt K; Rinaldo CH
    Virol J; 2020 Jan; 17(1):5. PubMed ID: 31924245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BK polyomavirus microRNA expression and sequence variation in polyomavirus-associated nephropathy.
    Virtanen E; Seppälä H; Helanterä I; Laine P; Lautenschlager I; Paulin L; Mannonen L; Auvinen P; Auvinen E
    J Clin Virol; 2018 May; 102():70-76. PubMed ID: 29518695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12.
    Hirsch HH; Yakhontova K; Lu M; Manzetti J
    Am J Transplant; 2016 Mar; 16(3):821-32. PubMed ID: 26639422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BK Polyomavirus-associated nephropathy managed by screening policy in a real-life setting.
    Raupp FVV; Meinerz G; da Silva CK; Bianco PCD; Goldani JC; Pegas KL; Stolfo JB; Garcia VD; Keitel E
    Transpl Infect Dis; 2020 Feb; 22(1):e13213. PubMed ID: 31724282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Mar; 35(3):375-382. PubMed ID: 30539254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human polyomavirus BK (BKPyV): virological background and clinical implications.
    Rinaldo CH; Tylden GD; Sharma BN
    APMIS; 2013 Aug; 121(8):728-45. PubMed ID: 23782063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acitretin and Retinoic Acid Derivatives Inhibit BK Polyomavirus Replication in Primary Human Proximal Renal Tubular Epithelial and Urothelial Cells.
    Wu Z; Graf FE; Hirsch HH
    J Virol; 2021 Jul; 95(15):e0012721. PubMed ID: 34011542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation.
    Korth J; Anastasiou OE; Bräsen JH; Brinkhoff A; Lehmann U; Kribben A; Dittmer U; Verheyen J; Wilde B; Ciesek S; Witzke O; Widera M
    J Clin Virol; 2019 Apr; 113():14-19. PubMed ID: 30771597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral DNA replication-dependent DNA damage response activation during BK polyomavirus infection.
    Verhalen B; Justice JL; Imperiale MJ; Jiang M
    J Virol; 2015 May; 89(9):5032-9. PubMed ID: 25694603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity of calcineurin inhibitors as a risk factor for BK polyomavirus replication after kidney transplantation.
    Krejčí K; Tichý T; Bednaříková J; Bartková M; Žamboch K; Orság J; Zadražil J
    J Med Virol; 2021 Jun; 93(6):3871-3879. PubMed ID: 32940913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BK Polyomavirus Requires the Mismatch Repair Pathway for DNA Damage Response Activation.
    Justice JL; Needham JM; Verhalen B; Jiang M; Thompson SR
    J Virol; 2022 Apr; 96(8):e0202821. PubMed ID: 35389233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
    Pape L; Tönshoff B; Hirsch HH;
    Nephrol Dial Transplant; 2016 May; 31(5):842-7. PubMed ID: 26590390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of immune suppressive agents on the BK-Polyomavirus non coding control region.
    Korth J; Anastasiou OE; Verheyen J; Dickow J; Sertznig H; Frericks N; Bleekmann B; Kribben A; Brinkhoff A; Wilde B; Sutter K; Dittmer U; Ciesek S; Witzke O; Widera M
    Antiviral Res; 2018 Nov; 159():68-76. PubMed ID: 30268912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.